Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SLC2A8 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
HNRNPD - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LIG4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MAP9 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MRPL19 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FZD7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MRPL50 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
AIMP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CFAP97 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CSE1L - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SNORD73A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TMEM150C - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RIOK3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DNAJC27 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
METTL14 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC30A5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RCBTB1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LARP1B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SVIP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on